Peter Soparkar - 19 Apr 2022 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Role
Chief Operating Officer and Chief Legal Officer
Signature
Peter Soparkar, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
ADVM
Transactions as of
19 Apr 2022
Net transactions value
+$24,994
Form type
4
Filing time
20 Apr 2022, 16:35:04 UTC
Previous filing
17 Mar 2022
Next filing
16 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADVM Common Stock Purchase $199 +175 +0.07% $1.14 258,806 19 Apr 2022 Direct
transaction ADVM Common Stock Purchase $24,795 +21,750 +8.4% $1.14 280,556 19 Apr 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Chief Operating Officer and Chief Legal Officer